ISIN | CH0445993279 |
---|---|
Valor Number | 44599327 |
Bloomberg Global ID | |
Fund Name | Unigestion Swiss Equities R |
Fund Provider |
Unigestion
Genève 12, Switzerland Phone: +41 22 704 41 11 Web: www.unigestion.com |
Fund Provider | Unigestion |
Representative in Switzerland | |
Distributor(s) |
Unigestion S.A. Genève 12 Phone: +41 22 704 41 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | The main objective of the fund is to achieve a long term performance equal to,or greater than,the SMI index,with a lower volatility while controlling the tracking error of the portfolio.This is achieved by using a quantitative method based on the construction of a "minimum variance" portfolio,i.e. the optimal portfolio having the lowest expected volatility or risk. |
Peculiarities |
Current Price * | 133.49 CHF | 16.01.2025 |
---|---|---|
Previous Price * | 132.52 CHF | 15.01.2025 |
52 Week High * | 134.81 CHF | 18.10.2024 |
52 Week Low * | 119.48 CHF | 09.02.2024 |
NAV * | 133.49 CHF | 16.01.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 80,613,678 | |
Unit/Share Assets *** | 2,890,866 | |
Trading Information SIX |
YTD Performance | +2.49% |
31.12.2024 - 16.01.2025
31.12.2024 16.01.2025 |
---|---|---|
1 month | +2.10% |
16.12.2024 - 16.01.2025
16.12.2024 16.01.2025 |
3 months | +0.02% |
16.10.2024 - 16.01.2025
16.10.2024 16.01.2025 |
6 months | +1.11% |
16.07.2024 - 16.01.2025
16.07.2024 16.01.2025 |
1 year | +8.62% |
16.01.2024 - 16.01.2025
16.01.2024 16.01.2025 |
2 years | +6.74% |
16.01.2023 - 16.01.2025
16.01.2023 16.01.2025 |
3 years | -1.15% |
17.01.2022 - 16.01.2025
17.01.2022 16.01.2025 |
5 years | +14.87% |
16.01.2020 - 16.01.2025
16.01.2020 16.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.61% | |
---|---|---|
Nestle SA | 11.26% | |
Roche Holding AG | 9.92% | |
Zurich Insurance Group AG | 8.21% | |
Swiss Re AG | 5.75% | |
ABB Ltd | 4.15% | |
Swisscom AG | 3.56% | |
Swiss Prime Site AG | 3.50% | |
PSP Swiss Property AG | 3.40% | |
UBS Group AG | 3.36% | |
Last data update | 30.11.2024 |
TER | 1.06% |
---|---|
TER date | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.06% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |